Comparison of Absorption of Vitamin D in Cystic Fibrosis

PHASE4CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

March 31, 2015

Study Completion Date

October 31, 2015

Conditions
Cystic Fibrosis
Interventions
DIETARY_SUPPLEMENT

Vitamin D Powder

Patients will be randomly assigned to a powder supplement of 100,000 IU vitamin D3. Randomization will be in blocks of 4 (meaning for every 4 subjects there will be 2 vitamin D and 2 placebo treated patients). Blood will be drawn by IV catheter at baseline, 2, 4, 8, 12, 24, 48, and 72 hours after vitamin D3 dosing

DIETARY_SUPPLEMENT

Vitamin D Oil

Patients will be randomly assigned to an oil based supplement of 100,000 IU vitamin D3. Randomization will be in blocks of 4 (meaning for every 4 subjects there will be 2 vitamin D and 2 placebo treated patients). Blood will be drawn by IV catheter at baseline, 2, 4, 8, 12, 24, 48, and 72 hours after vitamin D3 dosing

Trial Locations (1)

30322

Emory University Hospital, Atlanta

All Listed Sponsors
lead

Emory University

OTHER

NCT01880346 - Comparison of Absorption of Vitamin D in Cystic Fibrosis | Biotech Hunter | Biotech Hunter